Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 437

1.

Golgi-derived PI(4)P-containing vesicles drive late steps of mitochondrial division.

Nagashima S, Tábara LC, Tilokani L, Paupe V, Anand H, Pogson JH, Zunino R, McBride HM, Prudent J.

Science. 2020 Mar 20;367(6484):1366-1371. doi: 10.1126/science.aax6089.

PMID:
32193326
2.

Evaluation of the efficiency of dried blood spot-based measurement of hepatitis B and hepatitis C virus seromarkers.

Yamamoto C, Nagashima S, Isomura M, Ko K, Chuon C, Akita T, Katayama K, Woodring J, Hossain MS, Takahashi K, Tanaka J.

Sci Rep. 2020 Mar 2;10(1):3857. doi: 10.1038/s41598-020-60703-1.

3.

Long-term efficacy of the sodium-glucose cotransporter 2 inhibitor, ipragliflozin, in a case of type A insulin resistance syndrome.

Nagashima S, Wakabayashi T, Saito N, Takahashi M, Okada K, Ebihara K, Ishibashi S.

J Diabetes Investig. 2020 Feb 26. doi: 10.1111/jdi.13241. [Epub ahead of print]

4.

Multivesicular body sorting and the exosomal pathway are required for the release of rat hepatitis E virus from infected cells.

Primadharsini PP, Nagashima S, Takahashi M, Kobayashi T, Nishiyama T, Nishizawa T, Yasuda J, Mulyanto, Okamoto H.

Virus Res. 2020 Mar;278:197868. doi: 10.1016/j.virusres.2020.197868. Epub 2020 Jan 18.

PMID:
31962066
5.

The changing epidemiology of hepatitis B and C infections in Nanoro, rural Burkina Faso: a random sampling survey.

Lingani M, Akita T, Ouoba S, Nagashima S, Boua PR, Takahashi K, Kam B, Sugiyama A, Nikiema T, Yamamoto C, Somé A, Derra K, Ko K, Sorgho H, Tarnagda Z, Tinto H, Tanaka J.

BMC Infect Dis. 2020 Jan 15;20(1):46. doi: 10.1186/s12879-019-4731-7.

6.

Carboxyl-, sulfonyl-, and phosphate-terminal dendrimers as a nanoplatform with lymph node targeting.

Nishimoto Y, Nagashima S, Nakajima K, Ohira T, Sato T, Izawa T, Yamate J, Higashikawa K, Kuge Y, Ogawa M, Kojima C.

Int J Pharm. 2020 Feb 25;576:119021. doi: 10.1016/j.ijpharm.2020.119021. Epub 2020 Jan 7.

PMID:
31917298
7.

Critical role of CRAG, a splicing variant of centaurin-γ3/AGAP3, in ELK1-dependent SRF activation at PML bodies.

Nagashima S, Takeda K, Shiiba I, Higashi M, Fukuda T, Tokuyama T, Matsushita N, Nagano S, Araki T, Kaneko M, Shioi G, Inatome R, Yanagi S.

Sci Rep. 2019 Dec 27;9(1):20107. doi: 10.1038/s41598-019-56559-9.

8.

The effect of masticatory behaviour on generalized attention in heathy volunteers.

Nagashima S, Kimoto K, Ono Y, Ohno A, Hoshi N, Fuchigami K, Manabe Y.

Psychogeriatrics. 2019 Dec 27. doi: 10.1111/psyg.12493. [Epub ahead of print]

PMID:
31881113
9.

Phase II study of ramucirumab and docetaxel for previously treated non-small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study.

Takemoto S, Fukuda M, Yamaguchi H, Ikeda T, Akagi K, Tomono H, Umeyama Y, Dotsu Y, Taniguchi H, Gyotoku H, Senju H, Kitazaki T, Nakatomi K, Nagashima S, Fukuda M, Kinoshita A, Soda H, Mukae H.

Thorac Cancer. 2020 Feb;11(2):389-393. doi: 10.1111/1759-7714.13279. Epub 2019 Dec 18.

10.

An electrochemical aptamer-based sensor prepared by utilizing the strong interaction between a DNA aptamer and diamond.

Asai K, Yamamoto T, Nagashima S, Ogata G, Hibino H, Einaga Y.

Analyst. 2020 Jan 21;145(2):544-549. doi: 10.1039/c9an01976f. Epub 2019 Nov 25.

PMID:
31764923
11.

CAMDI interacts with the human memory-associated protein KIBRA and regulates AMPAR cell surface expression and cognition.

Fukuda T, Nagashima S, Inatome R, Yanagi S.

PLoS One. 2019 Nov 15;14(11):e0224967. doi: 10.1371/journal.pone.0224967. eCollection 2019.

12.

Myeloid HMG-CoA Reductase Determines Adipose Tissue Inflammation, Insulin Resistance, and Hepatic Steatosis in Diet-Induced Obese Mice.

Takei A, Nagashima S, Takei S, Yamamuro D, Murakami A, Wakabayashi T, Isoda M, Yamazaki H, Ebihara C, Takahashi M, Ebihara K, Ishibashi S.

Diabetes. 2020 Feb;69(2):158-164. doi: 10.2337/db19-0076. Epub 2019 Nov 5.

PMID:
31690648
13.

Treatment strategy for pediatric giant mucinous cystadenoma: A case report.

Watanabe S, Nagashima S, Onagi C, Yamazaki N, Shimada S, Sakai M, Yanai S, Haga Y, Ohara A, Kuroiwa M.

Pediatr Rep. 2019 Sep 24;11(3):8190. doi: 10.4081/pr.2019.8190. eCollection 2019 Sep 24.

14.

Atomic-Level Observation of Electrochemical Platinum Dissolution and Redeposition.

Nagashima S, Ikai T, Sasaki Y, Kawasaki T, Hatanaka T, Kato H, Kishita K.

Nano Lett. 2019 Oct 9;19(10):7000-7005. doi: 10.1021/acs.nanolett.9b02382. Epub 2019 Sep 16.

PMID:
31524402
15.

Dose escalation study of amrubicin and cisplatin with concurrent thoracic radiotherapy for limited-disease small cell lung cancer.

Shimada M, Yamaguchi H, Fukuda M, Tomono H, Honda N, Dotsu Y, Taniguchi H, Gyotoku H, Senju H, Takemoto S, Ikeda T, Nakatomi K, Nakamura Y, Nagashima S, Yamazaki T, Mukae H.

Cancer Chemother Pharmacol. 2019 Nov;84(5):1059-1064. doi: 10.1007/s00280-019-03940-0. Epub 2019 Sep 5.

PMID:
31486872
16.

Lifestyle habits associated with nocturnal urination frequency: The Nagahama study.

Tabara Y, Matsumoto T, Murase K, Setoh K, Kawaguchi T, Nagashima S, Funada S, Kosugi S, Hirai T, Nakayama T, Wakamura T, Chin K, Matsuda F; Nagahama study group.

Neurourol Urodyn. 2019 Nov;38(8):2359-2367. doi: 10.1002/nau.24156. Epub 2019 Sep 4.

PMID:
31486144
17.

Association of weak hip abduction strength with nocturia in older women: The Nagahama study.

Tabara Y, Ikezoe T, Matsumoto T, Murase K, Setoh K, Funada S, Kawaguchi T, Nagashima S, Kosugi S, Hirai T, Nakayama T, Wakamura T, Chin K, Ichihashi N, Tsuboyama T, Matsuda F.

Geriatr Gerontol Int. 2019 Oct;19(10):1010-1016. doi: 10.1111/ggi.13761. Epub 2019 Sep 1.

PMID:
31475427
18.

Antiviral and Virucidal Activities of Umesu Phenolics on Influenza Viruses.

Ikeda K, Nishide M, Tsujimoto K, Nagashima S, Kuwahara T, Mitani T, Koyama AH.

Jpn J Infect Dis. 2020 Jan 23;73(1):8-13. doi: 10.7883/yoken.JJID.2018.522. Epub 2019 Aug 30.

19.

IFN-λ3 as a host immune response in acute hepatitis E virus infection.

Murata K, Kang JH, Nagashima S, Matsui T, Karino Y, Yamamoto Y, Atarashi T, Oohara M, Uebayashi M, Sakata H, Matsubayashi K, Takahashi K, Arai M, Mishiro S, Sugiyama M, Mizokami M, Okamoto H.

Cytokine. 2020 Jan;125:154816. doi: 10.1016/j.cyto.2019.154816. Epub 2019 Aug 26.

PMID:
31465972
20.

High possibility of hepatocarcinogenesis in HBV genotype C1 infected Cambodians is indicated by 340 HBV C1 full-genomes analysis from GenBank.

Chuon C, Takahashi K, Matsuo J, Katayama K, Yamamoto C, Ko K, Hok S, Nagashima S, Akbar SMF, Tanaka J.

Sci Rep. 2019 Aug 21;9(1):12186. doi: 10.1038/s41598-019-48304-z.

21.

MITOL deletion in the brain impairs mitochondrial structure and ER tethering leading to oxidative stress.

Nagashima S, Takeda K, Ohno N, Ishido S, Aoki M, Saitoh Y, Takada T, Tokuyama T, Sugiura A, Fukuda T, Matsushita N, Inatome R, Yanagi S.

Life Sci Alliance. 2019 Aug 15;2(4). pii: e201900308. doi: 10.26508/lsa.201900308. Print 2019 Aug.

22.

Association between sleep disturbance and nocturnal blood pressure profiles by a linear mixed model analysis: the Nagahama study.

Matsumoto T, Tabara Y, Murase K, Setoh K, Kawaguchi T, Nagashima S, Kosugi S, Nakayama T, Wakamura T, Hirai T, Matsuda F, Chin K; Nagahama Study Group.

Sleep Med. 2019 Sep;61:104-109. doi: 10.1016/j.sleep.2019.01.049. Epub 2019 Mar 5.

PMID:
31402214
23.

Frequent nocturnal urination in older men is associated with arterial stiffness: The Nagahama study.

Tabara Y, Matsumoto T, Murase K, Setoh K, Kawaguchi T, Nagashima S, Kosugi S, Hirai T, Nakayama T, Wakamura T, Chin K, Matsuda F; and the Nagahama study group.

Hypertens Res. 2019 Dec;42(12):1996-2001. doi: 10.1038/s41440-019-0309-4. Epub 2019 Aug 9.

PMID:
31399710
24.

MITOL prevents ER stress-induced apoptosis by IRE1α ubiquitylation at ER-mitochondria contact sites.

Takeda K, Nagashima S, Shiiba I, Uda A, Tokuyama T, Ito N, Fukuda T, Matsushita N, Ishido S, Iwawaki T, Uehara T, Inatome R, Yanagi S.

EMBO J. 2019 Aug 1;38(15):e100999. doi: 10.15252/embj.2018100999. Epub 2019 Jun 13.

25.

Antiviral candidates against the hepatitis E virus (HEV) and their combinations inhibit HEV growth in in vitro.

Nishiyama T, Kobayashi T, Jirintai S, Nagashima S, Primadharsini PP, Nishizawa T, Okamoto H.

Antiviral Res. 2019 Oct;170:104570. doi: 10.1016/j.antiviral.2019.104570. Epub 2019 Jul 27.

PMID:
31362004
26.

The spontaneous clearance of hepatitis E virus (HEV) and emergence of HEV antibodies in a transfusion-transmitted chronic hepatitis E case after completion of chemotherapy for acute myeloid leukemia.

Okano H, Nakano T, Ito R, Tanaka A, Hoshi Y, Matsubayashi K, Asakawa H, Nose K, Tsuruga S, Tochio T, Kumazawa H, Isono Y, Tanaka H, Matsusaki S, Sase T, Saito T, Mukai K, Nishimura A, Kawakami K, Nagashima S, Takahashi M, Okamoto H.

Clin J Gastroenterol. 2019 Jul 24. doi: 10.1007/s12328-019-01024-3. [Epub ahead of print]

PMID:
31342463
27.

Phase II study of nedaplatin and amrubicin as first-line treatment for advanced squamous cell lung cancer.

Taniguchi H, Yamaguchi H, Dotsu Y, Shimada M, Gyotoku H, Senju H, Takemoto S, Kitazaki T, Fukuda M, Ogawara D, Soda H, Nakatomi K, Sugasaki N, Kinoshita A, Nagashima S, Ikeda T, Nakamura Y, Sakamoto N, Obase Y, Fukuda M, Mukae H.

Thorac Cancer. 2019 Sep;10(9):1764-1769. doi: 10.1111/1759-7714.13134. Epub 2019 Jul 16.

28.

Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017.

Ork V, Woodring J, Shafiqul Hossain M, Wasley A, Nagashima S, Yamamoto C, Chuon C, Sugiyama A, Ohisa M, Akita T, Ko K, Mao B, Tanaka J.

Vaccine. 2019 Aug 14;37(35):5059-5066. doi: 10.1016/j.vaccine.2019.06.073. Epub 2019 Jul 5.

29.

Acute Liver Failure Caused by the Transmission of Hepatitis B Virus from the Spouse after 38 Years of Marriage.

Sato N, Watanabe S, Miura K, Goka R, Morimoto N, Takaoka Y, Nomoto H, Tsukui M, Isoda N, Nagashima S, Takahashi M, Okamoto H, Yamamoto H.

Intern Med. 2019 Oct 15;58(20):2963-2968. doi: 10.2169/internalmedicine.3028-19. Epub 2019 Jun 27.

30.

A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis in Heart and Kidney Transplant Recipients in Japan.

Owada Y, Oshiro Y, Inagaki Y, Harada H, Fujiyama N, Kawagishi N, Yagisawa T, Usui J, Akutsu N, Itabashi Y, Saito K, Watarai Y, Ichimaru N, Imamura R, Kyakuno M, Ide K, Shibuya Y, Okabe Y, Ono M, Sasaki K, Shiose A, Yamagishi K, Ohnishi H, Nagashima S, Takahashi M, Yuzawa K, Okamoto H, Ohkohchi N.

Transplantation. 2020 Feb;104(2):437-444. doi: 10.1097/TP.0000000000002801.

31.

Association of the spot urine sodium-to-potassium ratio with blood pressure is independent of urinary Na and K levels: The Nagahama study.

Higo Y, Nagashima S, Tabara Y, Setoh K, Kawaguchi T, Takahashi Y, Kosugi S, Nakayama T, Matsuda F, Wakamura T; Nagahama study group.

Hypertens Res. 2019 Oct;42(10):1624-1630. doi: 10.1038/s41440-019-0276-9. Epub 2019 Jun 10.

PMID:
31182861
32.

Genetic Variability and Evolution of Hepatitis E Virus.

Primadharsini PP, Nagashima S, Okamoto H.

Viruses. 2019 May 18;11(5). pii: E456. doi: 10.3390/v11050456. Review.

33.

Changing clinical and molecular characteristics of hepatitis E virus infection in Mie Prefecture, Japan: Disappearance of indigenous subtype 3e strains.

Nakano T, Okano H, Takahashi M, Nagashima S, Shiraki K, Oya Y, Inoue H, Ohmori S, Tsukimoto M, Ishida S, Fujimoto S, Kobayashi M, Yamawaki M, Kumagai M, Ninomiya J, Maegawa T, Kojima Y, Araki J, Hamaoka S, Horiike S, Yoshimura H, Takeuchi K, Itoh K, Akachi S, Uraki S, Yamamoto N, Ogura S, Sugimoto K, Yoshikawa K, Hasegawa H, Iwasa M, Takei Y, Okamoto H.

Hepatol Res. 2019 Sep;49(9):1003-1014. doi: 10.1111/hepr.13357. Epub 2019 Jun 7.

PMID:
31026368
34.

Screening of novel drugs for inhibiting hepatitis E virus replication.

Nishiyama T, Kobayashi T, Jirintai S, Kii I, Nagashima S, Prathiwi Primadharsini P, Nishizawa T, Okamoto H.

J Virol Methods. 2019 Aug;270:1-11. doi: 10.1016/j.jviromet.2019.04.017. Epub 2019 Apr 17.

PMID:
31004661
35.

Very low prevalence of anti-HAV in Japan: high potential for future outbreak.

Yamamoto C, Ko K, Nagashima S, Harakawa T, Fujii T, Ohisa M, Katayama K, Takahashi K, Okamoto H, Tanaka J.

Sci Rep. 2019 Feb 6;9(1):1493. doi: 10.1038/s41598-018-37349-1.

36.

A Questionnaire Survey on the Sequence of Events Prior to Undergoing Colonoscopy: The Influence of the Behavioral Response after a Fecal Occult Blood Test on the Early Detection of Colorectal Cancer.

Yuge R, Fujii T, Shinagawa K, Sanomura Y, Oka S, Nagashima S, Ohisa M, Kitadai Y, Tanaka S, Kohno N, Tanaka J.

Intern Med. 2019 Jun 1;58(11):1541-1547. doi: 10.2169/internalmedicine.1826-18. Epub 2019 Feb 1.

37.

Osimertinib in Elderly Patients with Epidermal Growth Factor Receptor T790M-Positive Non-Small-Cell Lung Cancer Who Progressed During Prior Treatment: A Phase II Trial.

Nakao A, Hiranuma O, Uchino J, Sakaguchi C, Kita T, Hiraoka N, Ishizuka T, Kubota Y, Kawasaki M, Goto Y, Imai H, Hattori N, Nakatomi K, Uramoto H, Uryu K, Fukuda M, Uchida Y, Yokoyama T, Akai M, Mio T, Nagashima S, Chihara Y, Tamiya N, Kaneko Y, Mouri T, Yamada T, Yoshimura K, Fujita M, Takayama K.

Oncologist. 2019 May;24(5):593-e170. doi: 10.1634/theoncologist.2019-0003. Epub 2019 Jan 16.

38.

Full-genome characterization of the RIVM-HAV16-090-like hepatitis A virus strains recovered from Japanese men who have sex with men, with sporadic acute hepatitis A.

Watanabe S, Morimoto N, Miura K, Takaoka Y, Nomoto H, Tsukui M, Isoda N, Ohnishi H, Nagashima S, Takahashi M, Okamoto H, Yamamoto H.

Hepatol Res. 2019 May;49(5):521-530. doi: 10.1111/hepr.13313. Epub 2019 Feb 20.

PMID:
30645783
39.

Phase II trial of a non-platinum triplet for patients with advanced non-small cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNA.

Takemoto S, Nakamura Y, Gyoutoku H, Senju H, Ogawara D, Ikeda T, Yamaguchi H, Kitazaki T, Nakano H, Nakatomi K, Tomari S, Sato S, Nagashima S, Fukuda M, Mukae H.

Thorac Cancer. 2019 Mar;10(3):452-458. doi: 10.1111/1759-7714.12958. Epub 2019 Jan 9.

40.

Acquisition rate of antibody to hepatitis B surface antigen among medical and dental students in Japan after three-dose hepatitis B vaccination.

Nagashima S, Yamamoto C, Ko K, Chuon C, Sugiyama A, Ohisa M, Akita T, Katayama K, Yoshihara M, Tanaka J.

Vaccine. 2019 Jan 3;37(1):145-151. doi: 10.1016/j.vaccine.2018.11.019. Epub 2018 Nov 16.

41.

Pid3-I1 is a race-specific partial-resistance allele at the Pid3 blast resistance locus in rice.

Inukai T, Nagashima S, Kato M.

Theor Appl Genet. 2019 Feb;132(2):395-404. doi: 10.1007/s00122-018-3227-y. Epub 2018 Nov 2.

PMID:
30390130
42.

Myeloid HMG-CoA (3-Hydroxy-3-Methylglutaryl-Coenzyme A) Reductase Determines Atherosclerosis by Modulating Migration of Macrophages.

Sakai K, Nagashima S, Wakabayashi T, Tumenbayar B, Hayakawa H, Hayakawa M, Karasawa T, Ohashi K, Yamazaki H, Takei A, Takei S, Yamamuro D, Takahashi M, Yagyu H, Osuga JI, Takahashi M, Tominaga SI, Ishibashi S.

Arterioscler Thromb Vasc Biol. 2018 Nov;38(11):2590-2600. doi: 10.1161/ATVBAHA.118.311664.

PMID:
30354246
43.

Inflammasome Activation Aggravates Cutaneous Xanthomatosis and Atherosclerosis in ACAT1 (Acyl-CoA Cholesterol Acyltransferase 1) Deficiency in Bone Marrow.

Wakabayashi T, Takahashi M, Yamamuro D, Karasawa T, Takei A, Takei S, Yamazaki H, Nagashima S, Ebihara K, Takahashi M, Ishibashi S.

Arterioscler Thromb Vasc Biol. 2018 Nov;38(11):2576-2589. doi: 10.1161/ATVBAHA.118.311648.

PMID:
30354239
44.

Loss of ACAT1 Attenuates Atherosclerosis Aggravated by Loss of NCEH1 in Bone Marrow-Derived Cells.

Yamazaki H, Takahashi M, Wakabayashi T, Sakai K, Yamamuro D, Takei A, Takei S, Nagashima S, Yagyu H, Sekiya M, Ebihara K, Ishibashi S.

J Atheroscler Thromb. 2019 Mar 1;26(3):246-259. doi: 10.5551/jat.44040. Epub 2018 Oct 4.

45.

Day-to-Day Home Blood Pressure Variability and Orthostatic Hypotension: The Nagahama Study.

Tabara Y, Matsumoto T, Murase K, Setoh K, Kawaguchi T, Nagashima S, Kosugi S, Nakayama T, Wakamura T, Hirai T, Chin K, Matsuda F; Nagahama study group.

Am J Hypertens. 2018 Nov 13;31(12):1278-1285. doi: 10.1093/ajh/hpy131.

PMID:
30239598
46.

Acupuncture for reducing pruritus induced by intrathecal morphine at elective cesarean delivery: a placebo-controlled, randomized, double-blind trial.

Mazda Y, Kikuchi T, Yoshimatsu A, Kato A, Nagashima S, Terui K.

Int J Obstet Anesth. 2018 Nov;36:66-76. doi: 10.1016/j.ijoa.2018.07.001. Epub 2018 Jul 27.

PMID:
30131262
47.

Mitochondrial dynamics: overview of molecular mechanisms.

Tilokani L, Nagashima S, Paupe V, Prudent J.

Essays Biochem. 2018 Jul 20;62(3):341-360. doi: 10.1042/EBC20170104. Print 2018 Jul 20. Review.

48.

Immunoexpression of SOX-2 in oral leukoplakia.

Luiz ST, Modolo F, Mozzer I, Dos Santos EC, Nagashima S, Camargo Martins AP, de Azevedo MLV, Azevedo Alanis LR, Hardy AMTG, de Moraes RS, Aguiar MCF, Ignácio SA, Jham BC, Noronha L, Johann ACBR.

Oral Dis. 2018 Nov;24(8):1449-1457. doi: 10.1111/odi.12922. Epub 2018 Jul 18.

PMID:
29938872
49.

A 79-year-old Woman with Acute Hepatitis B Caused by the Infection of Subgenotype D1 Hepatitis B Virus in Japan: A Case Study.

Hashimoto K, Miura K, Takaoka Y, Nomoto H, Watanabe S, Tsukui M, Morimoto N, Isoda N, Nagashima S, Takahashi M, Okamoto H, Yamamoto H.

Intern Med. 2018 Nov 1;57(21):3099-3104. doi: 10.2169/internalmedicine.0977-18. Epub 2018 Jun 6.

50.

Nocturia and increase in nocturnal blood pressure: the Nagahama study.

Matsumoto T, Tabara Y, Murase K, Setoh K, Kawaguchi T, Nagashima S, Kosugi S, Nakayama T, Wakamura T, Hirai T, Matsuda F, Chin K; Nagahama study group.

J Hypertens. 2018 Nov;36(11):2185-2192. doi: 10.1097/HJH.0000000000001802.

PMID:
29846331

Supplemental Content

Loading ...
Support Center